Concepedia

Treatment with low-dose sorafenib in combination with a novel benzimidazole derivative bearing a pyrolidine side chain provides synergistic anti-proliferative effects against human liver cancer

Ming-Hua Hsu, Shih‐Ming Hsu, Yu-Cheng Kuo, Chih-Yu Liu, Cheng-Ying Hsieh, Yuh‐Ching Twu, Chung-Kwe Wang, Yuan-Hsi Wang, Yi‐Jen Liao

RSC Advances · 2017 · 12 citations · 42 references

DOIFull text

Open access

Concepts

Abstract

Hepatocellular carcinoma (HCC) is one of the most prevalent malignancies and deadliest cancers in the world.

References

42

Sorafenib in Advanced Hepatocellular Carcinoma

Josep M. Llovet, Sergio Ricci, Vincenzo Mazzaferro et al. · New England Journal of Medicine · 2008 · 13K citations · Full text

, , +12

Cancer statistics, 2013

Rebecca L. Siegel, Deepa Naishadham, Ahmedin Jemal · CA A Cancer Journal for Clinicians · 2013 · 11.9K citations · Full text

, , +16

Management of Hepatocellular Carcinoma: An Update Δσ

Jordi Bruix, Morris Sherman · Hepatology · 2011 · 8.1K citations · Full text

, , +14

Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors

Ting‐Chao Chou, Paul Talalay · Advances in Enzyme Regulation · 1984 · 7.2K citations

, , +16

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

Ann‐Lii Cheng, Yoon‐Koo Kang, Zhendong Chen et al. · The Lancet Oncology · 2008 · 5.8K citations

, , +11